RESCRIPTOR (ViiV Healthcare Company)


Welcome to the PulseAid listing for the RESCRIPTOR drug offered from ViiV Healthcare Company. This Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [Chemical/Ingredient],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: ViiV Healthcare Company
NON-PROPRIETARY NAME: delavirdine mesylate
SUBSTANCE NAME: DELAVIRDINE MESYLATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [Chemical/Ingredient],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2010-10-13
END MARKETING DATE: 0000-00-00


RESCRIPTOR HUMAN PRESCRIPTION DRUG Details:

Item DescriptionRESCRIPTOR from ViiV Healthcare Company
LABELER NAME: ViiV Healthcare Company
DEA SCHEDULE:
ACTIVE STRENGTH: 100(mg/1)
START MARKETING DATE: 2010-10-13
END MARKETING DATE: 0000-00-00
PRODUCT ID: 49702-209_bd0a3b2a-cb86-4a9f-badc-4f9f8037dc18
PRODUCT NDC: 49702-209
APPLICATION NUMBER: NDA020705

Other DELAVIRDINE MESYLATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
KAISER FOUNDATION HOSPITALSRESCRIPTOR
ViiV Healthcare CompanyRESCRIPTOR